Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited
Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited is a converted/closed company incorporated on 20 May 2015 with the registered office located in . Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited was registered 10 years ago.
Status
Converted/closed
Company No
FC032584
Overseas company
Age
10 years
Incorporated 20 May 2015
Size
Large
Turnover is over £54M
Over 250 employees
Confirmation
Exempt
FC companies are not required to submit this
Accounts
Not Submitted
Awaiting first accounts
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Edinburgh Pharmaceutical Industries Limited and are mutual people.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Edinburgh Pharmaceutical Industries Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2017)
Period Ended
31 Dec 2017
For period 31 Dec ⟶ 31 Dec 2017
Traded for 12 months
Cash in Bank
£3.83B
Decreased by £1.06B (-22%)
Turnover
£30.19B
Increased by £2.3B (+8%)
Employees
99.35K
Decreased by 478 (-0%)
Total Assets
£56.38B
Decreased by £2.7B (-5%)
Total Liabilities
-£56.45B
Decreased by £1.51B (-3%)
Net Assets
-£68M
Decreased by £1.19B (-106%)
Debt Ratio (%)
100%
Increased by 2.02% (+2%)
Get Credit Report
Discover Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
